P7- Other serious chronic disease (Novo Nordisk Capital Markets Day 2022)

Serious chronic disease presentation

Ludovic Helfgott, EVP Rare disease
Martin Holst Lange, EVP Development
Camilla Sylvest, EVP Commercial Strategy and Corporate Affairs
Karsten Munk Knudsen, EVP and CFO